Literature DB >> 23136041

Improving risk assessment.

Donna M Dambach1, Hirdesh Uppal.   

Abstract

Widespread sharing and analysis of clinical trial data and a U.S. government initiative to engineer nonclinical cell-based models that mimic human biological processes have the potential to improve predictions of drug-related adverse events.

Entities:  

Mesh：

Year:  2012        PMID： 23136041     DOI： 10.1126/scitranslmed.3003497

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  6 in total

Review 1.  Use of porous membranes in tissue barrier and co-culture models.

Authors:  Henry H Chung; Marcela Mireles; Bradley J Kwarta; Thomas R Gaborski
Journal:  Lab Chip       Date:  2018-06-12       Impact factor: 6.799

Review 2.  Organs-on-chips at the frontiers of drug discovery.

Authors:  Eric W Esch; Anthony Bahinski; Dongeun Huh
Journal:  Nat Rev Drug Discov       Date:  2015-03-20       Impact factor: 84.694

3.  Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs.

Authors:  Lauran Madden; Mark Juhas; William E Kraus; George A Truskey; Nenad Bursac
Journal:  Elife       Date:  2015-01-09       Impact factor: 8.140

4.  An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances.

Authors:  Tino Vollmer; Börje Ljungberg; Vera Jankowski; Joachim Jankowski; Griet Glorieux; Bernd G Stegmayr
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

Review 5.  3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations.

Authors:  Isra Marei; Tala Abu Samaan; Maryam Ali Al-Quradaghi; Asmaa A Farah; Shamin Hayat Mahmud; Hong Ding; Chris R Triggle
Journal:  Front Cardiovasc Med       Date:  2022-03-04

Review 6.  Three-Dimensional Cell Cultures in Drug Discovery and Development.

Authors:  Ye Fang; Richard M Eglen
Journal:  SLAS Discov       Date:  2017-06       Impact factor: 3.341
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.